Variant report
Variant | esv1828845 |
---|---|
Chromosome Location | chr11:18933129-18941412 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:12)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:12 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F4 | chr11:18940787-18941074 | MCF10A-Er-Src | breast: | n/a | n/a |
2 | GATA3 | chr11:18935296-18935542 | SH-SY5Y | brain: | n/a | n/a |
3 | MAFK | chr11:18940601-18940886 | HepG2 | liver: | n/a | n/a |
4 | PBX3 | chr11:18939968-18940081 | GM12878 | blood: | n/a | n/a |
5 | POLR2A | chr11:18934642-18934690 | H1-hESC | embryonic stem cell: | n/a | n/a |
6 | POLR2A | chr11:18935901-18936310 | H1-neurons | neurons: | n/a | n/a |
7 | POLR2A | chr11:18934711-18934744 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | POLR2A | chr11:18935427-18935624 | GM12878 | blood: | n/a | n/a |
9 | SP1 | chr11:18934401-18934811 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | TEAD4 | chr11:18934394-18934717 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | TEAD4 | chr11:18934355-18934887 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | ZNF263 | chr11:18936692-18937013 | HEK293-T-REx | kidney: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000255536 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576019185 | chr11:18934032-18934033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138517980 | chr11:18934061-18934062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531948846 | chr11:18934078-18934079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550172015 | chr11:18934107-18934108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570207952 | chr11:18934123-18934124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537795006 | chr11:18934139-18934140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186165801 | chr11:18934228-18934229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567875474 | chr11:18934239-18934240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192089837 | chr11:18934257-18934258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182079694 | chr11:18934323-18934324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs578150712 | chr11:18934339-18934340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538986235 | chr11:18934363-18934364 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs557370007 | chr11:18934382-18934383 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs575436281 | chr11:18934384-18934385 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs372024258 | chr11:18934392-18934393 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs187633409 | chr11:18934440-18934441 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs566533150 | chr11:18934442-18934443 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs572675303 | chr11:18934443-18934444 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs540055276 | chr11:18934449-18934450 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs564599554 | chr11:18934488-18934489 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs111365015 | chr11:18934491-18934492 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs533665298 | chr11:18934549-18934550 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs532081377 | chr11:18934592-18934593 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs543861823 | chr11:18934601-18934602 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs562537437 | chr11:18934633-18934634 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs531089854 | chr11:18934672-18934673 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs145525481 | chr11:18934687-18934688 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs559839709 | chr11:18934711-18934712 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs116767581 | chr11:18934716-18934717 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs547216286 | chr11:18934739-18934740 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs571763476 | chr11:18934761-18934762 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs539174278 | chr11:18934782-18934783 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs558676174 | chr11:18934828-18934829 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs576628835 | chr11:18934829-18934830 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs557065571 | chr11:18934843-18934844 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs1825287 | chr11:18934875-18934876 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs549377854 | chr11:18935357-18935358 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs144751233 | chr11:18935362-18935363 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs186897085 | chr11:18935364-18935365 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs567956594 | chr11:18935380-18935381 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs576152414 | chr11:18935453-18935454 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs190165146 | chr11:18935454-18935455 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs533874568 | chr11:18935470-18935471 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs182741801 | chr11:18935490-18935491 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs150642684 | chr11:18935507-18935508 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs78728960 | chr11:18935568-18935569 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs556183379 | chr11:18935582-18935583 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs532707225 | chr11:18935942-18935943 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs139817744 | chr11:18935995-18935996 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs78745071 | chr11:18936008-18936009 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Lung cancer | 17086460 | CNVD |
Uterine serous papillary cancer | 19536090 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:18934000-18934600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr11:18934200-18934400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr11:18934200-18934600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr11:18934400-18934800 | Enhancers | H1 Cell Line | embryonic stem cell |